Free webinar on demand

Need to know whether UK value-based-pricing represents an opportunity or a threat in terms of patients' access to new therapies? Curious to learn whether proposed changes to UK healthcare are likely to have an effect internationally in future, and also what role NICE will play? Sign up to watch our on demand webinar in which industry experts give their view on current and future UK healthcare challenges and opportunities

Coming soon

We want you to have a say in the topics that matter to you.

To ensure we are hitting the right note, we will run a survey after the first webinar to find out what matters to you. The next two events will have an EU focus but other than that, we are open to suggestions!

Market access revolution; stakeholder devolution? The changing face of the UK healthcare scene

In most global markets, the internal stakeholder structure is changing (e.g. UK commissioning groups, German sick funds, US healthcare reform). This has resulted in shifts in power and influence. Changes to the classic market access model of national pricing and reimbursement/access are also happening.

Can the UK learn from those markets that have already found ways to deal effectively with radical change? What can those markets learn from the UK's response to access pressures?

View on demand to see speakers from Sudler & Hennessey, Pharmaceutical Market Europe and Kantar Health, and industry experts to debate this vital topic. The debate was chaired by David Fisher from Pharmaceutical Market Europe.